Skip to content

Novavax NVAX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin85%-8.5pp93.5%+1.7pp91.8%+3.5pp88.3%+0.8pp87.4%+17.2pp
Operating margin-13.1%-53.4pp40.3%+11.4pp28.9%-3.7pp32.6%-0.2pp32.8%+69.3pp
Net margin-14.7%-53.9pp39.2%+7.1pp32.1%-7.1pp39.2%+1.1pp38.1%+65.6pp
Efficiency
Asset turnover0.5×-0.3×0.8×+0.1×0.7×+0.1×0.7×-0.3×0.9×+0.5×
Liquidity
Current ratio2.5×+0.4×2.1×-0.1×2.3×-0.1×2.4×+0.3×2.1×+1.1×
Per Share
Book value per share-$0.89-20.1%-$0.74+23.5%-$0.97-555%$0.21+150%-$0.43+89.6%
Valuation
Market capitalization$1.46B+41.0%$1.09B-22.5%$1.41B+34.0%$1.05B+2.0%$1.03B-19.9%
Price / sales2.5×+1.6×-0.4×1.3×+0.3×+0.2×0.8×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Novavax's profit margins?
Novavax (NVAX) runs a 85.0% gross margin and a -13.1% operating margin, with a -14.7% net margin.
Where do Novavax's ratios come from?
Every ratio is computed from Novavax's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.